Mai Abdelgawad

Mrs. Mai Abdelgawad

Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
Mai AbdelgawadMai Abdelgawad
Mai Abdelgawad
NBNourhan Saied Bakry
Nourhan Saied Bakry
AFA.A. Farghali
A.A. Farghali
AAAhmed Abdel-Latif
Ahmed Abdel-Latif
Ahmed LotfyAhmed Lotfy
Ahmed Lotfy
Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a cytokine storm and acute respiratory distress syndrome, the leading cause of COVID-19-related mortality and morbidity. So far, no therapies have succeeded in circumventing the exacerbated immune response or cytokine storm associated with COVID-19. Mesenchymal stem cells (MSCs), through their immunomodulatory and regenerative activities, mostly mediated by their paracrine effect and extracellular vesicle production, have therapeutic potential in many autoimmune, inflammatory, and degenerative diseases. In this paper, we review clinical studies on the use of MSCs for COVID-19 treatment, including the salutary effects of MSCs on the pathophysiology of COVID-19 and the immunomodulation of the cytokine storm. Ongoing clinical trial designs, cell sources, dose and administration, and populations are summarized, and the paracrine mode of benefit is discussed. We also offer suggestions for optimizing MSC-based therapies, including genetic engineering, strategies for cell surface modification, nanotechnology applications, and combination therapies.

14 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
NANesma E. Abdelaal
Nesma E. Abdelaal
BEREKET MOLLA TANGABEREKET MOLLA TANGA
BEREKET MOLLA TANGA
Mai AbdelgawadMai Abdelgawad
Mai Abdelgawad
SASahar Allam
Sahar Allam
MAMostafa Fathi Abdelhai
Mostafa Fathi Abdelhai
Jongki ChoJongki Cho
Jongki Cho
Male infertility is a major health problem affecting about 8–12% of couples worldwide. Spermatogenesis starts in the early fetus and completes after puberty, passing through different stages. Male infertility can result from primary or congenital, acquired, or idiopathic causes. The absence of sperm in semen, or azoospermia, results from non-obstructive causes (pretesticular and testicular), and post-testicular obstructive causes. Several medications such as antihypertensive drugs, antidepressants, chemotherapy, and radiotherapy could lead to impaired spermatogenesis and lead to a non-obstructive azoospermia. Spermatogonial stem cells (SSCs) are the basis for spermatogenesis and fertility in men. SSCs are characterized by their capacity to maintain the self-renewal process and differentiation into spermatozoa throughout the male reproductive life and transmit genetic information to the next generation. SSCs originate from gonocytes in the postnatal testis, which originate from long-lived primordial germ cells during embryonic development. The treatment of infertility in males has a poor prognosis. However, SSCs are viewed as a promising alternative for the regeneration of the impaired or damaged spermatogenesis. SSC transplantation is a promising technique for male infertility treatment and restoration of spermatogenesis in the case of degenerative diseases such as cancer, radiotherapy, and chemotherapy. The process involves isolation of SSCs and cryopreservation from a testicular biopsy before starting cancer treatment, followed by intra-testicular stem cell transplantation. In general, treatment for male infertility, even with SSC transplantation, still has several obstacles. The efficiency of cryopreservation, exclusion of malignant cells contamination in cancer patients, and socio-cultural attitudes remain major challenges to the wider application of SSCs as alternatives. Furthermore, there are limitations in experience and knowledge regarding cryopreservation of SSCs. However, the level of infrastructure or availability of regulatory approval to process and preserve testicular tissue makes them tangible and accurate therapy options for male infertility caused by non-obstructive azoospermia, though in their infancy, at least to date.

1 November 2020 in Biotechnology Advances
Verified
Journal Article
Open access
Yasser GaberYasser Gaber
Yasser Gaber
BRBoshra Rashad
Boshra Rashad
RHRasha Hussein
Rasha Hussein
Mai AbdelgawadMai Abdelgawad
Mai Abdelgawad
NANourhan S. Ali
Nourhan S. Ali
AVAnikó Várnai
Anikó Várnai
Lytic polysaccharide monooxygenases (LPMOs) are relatively new enzymes that have been discovered 10 years ago. LPMOs comprise a diverse group of enzymes which play a pivotal role in the depolymerization of sugar-based biopolymers including cellulose, hemicellulose, chitin, and starch. Their mechanism of action relies on the correct coordination of a copper ion in the active site, which is partly composed of the N-terminal histidine. Therefore, correct secretion and folding of these copper-enzymes is fundamental for obtaining a catalytic activity. LPMOs occur in all kingdoms of life; they have been found in viruses, bacteria and eukaryotes, including fungi, plants and animals. In many cases, using homologous expression of these proteins is not feasible and an alternative organism, which can be cultured and is able to heterologously express the protein of interest, is required for studying enzyme properties. Therefore, we made an extensive compilation of expression techniques used for LPMOs the expression and characterization of which have been reported to date. In the current review, we provide a summary of the different techniques, including expression hosts and vectors, secretion methods, and culturing conditions, that have been used for the overexpression and production of this important class of enzymes at laboratory scale. Herein, we compare these techniques and assess their advantages and disadvantages.

31 August 2019 in Reviews in the Neurosciences
Verified
Journal Article
Closed access
PDF file
Ahmed LotfyAhmed Lotfy
Ahmed Lotfy
NANourhan S. Ali
Nourhan S. Ali
Mai AbdelgawadMai Abdelgawad
Mai Abdelgawad
MSMohamed Salama
Mohamed Salama
Multiple sclerosis (MS) is a progressive and debilitating neurological condition in which the immune system abnormally attacks the myelin sheath insulating the nerves. Mesenchymal stem cells (MSCs) are found in most adult tissues and play a significant systemic role in self-repair. MSCs have promising therapeutic effects in many diseases, such as autoimmune diseases, including MS. MSCs have been tested in MS animal models, such as experimental autoimmune encephalomyelitis. Other studies have combined other agents with MSCs, genetically modified MSCs, or used culture medium from MSCs. In this review, we will summarize these studies and compare the main factors in each study, such as the source of MSCs, the type of animal model, the route of injection, the number of injected cells, and the mechanism of action.

23 December 2021 in The Open COVID Journal
Verified
Journal Article
Open access
PDF file
AAAbdallah S. Abdelsattar
Abdallah S. Abdelsattar
ZEZahraa M. El-Awadly
Zahraa M. El-Awadly
Mai AbdelgawadMai Abdelgawad
Mai Abdelgawad
FMFayrouz Mahmoud
Fayrouz Mahmoud
SASahar A. Allam
Sahar A. Allam
MHMohamed Helal
Mohamed Helal
The COVID-19 pandemic first appeared in Wuhan, China, in December 2019 in a cluster of pneumonia patients. The causative agent was found to be SARS-CoV-2. Here, we are summarizing current treatment strategies and highlighting the role of bioinformatics, molecular modeling, and structural biology during the COVID-19 pandemic. There are different pharmacological treatments, mostly repurposed drugs, employed for the treatment of COVID-19, including antiviral drugs, corticosteroids, biologic drugs, antibiotics, antifungal agents, and anticoagulants. Some immune-based therapies are also under evaluation, including convalescent plasma, IL-1, IL-6 inhibitors, and interferons. Different bioinformatics networks are established to provide information about the structure, transcriptome, and pathogenicity of the virus. The genotyping analysis for SARS-CoV-2 is also useful in identifying different mutations, SNPs, and conservative domains along the viral genome. Cryo-EM and X-ray diffraction had a crucial role in determining the structure of viral proteins such as spike (S) protein, main protease, and RdRp. NMR had a minor role and determining the structure of nucleocapsid (N) protein only. Several docking studies were performed to predict the interaction of certain FDA-approved drugs with known efficacy and toxicity, while others used natural products. Among different study types, in silico drug prediction and repurposing have the lowest risk with less off-target results. Therefore, bioinformatics and in silico studies have an important role during pandemics in providing information about viral structure and function and predicting potential treatments.

30 September 2021 in Human Cell
Verified
Journal Article
Closed access
PDF file
NBNourhan Saied Bakry
Nourhan Saied Bakry
Mai AbdelgawadMai Abdelgawad
Mai Abdelgawad
AAAhmed Abdel-Latif
Ahmed Abdel-Latif
Ahmed LotfyAhmed Lotfy
Ahmed Lotfy